Zou X - Search Results

1

Personalizing risk stratification by addition of PAK1 expression to TNM staging: improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma.

Li Z, Zou X, Xie L, Chen H, Chen Y, Yeung SC, Zhang H. Li Z, et al. Among authors: zou x. Int J Cancer. 2015 Apr 1;136(7):1636-45. doi: 10.1002/ijc.29167. Epub 2014 Sep 4. Int J Cancer. 2015. PMID: 25159681

2

PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy.

Huang YT, Li FF, Ke C, Li Z, Li ZT, Zou XF, Zheng XX, Chen YP, Zhang H. Huang YT, et al. J Transl Med. 2013 Oct 3;11:245. doi: 10.1186/1479-5876-11-245. J Transl Med. 2013. PMID: 24090193 Free PMC article.

3

Prognostic importance and therapeutic implications of PAK1, a drugable protein kinase, in gastroesophageal junction adenocarcinoma.

Li Z, Zou X, Xie L, Dong H, Chen Y, Liu Q, Wu X, Zhou D, Tan D, Zhang H. Li Z, et al. Among authors: zou x. PLoS One. 2013 Nov 13;8(11):e80665. doi: 10.1371/journal.pone.0080665. eCollection 2013. PLoS One. 2013. PMID: 24236193 Free PMC article.

4

Lymph node ratio-based staging system for esophageal squamous cell carcinoma.

Chen SB, Weng HR, Wang G, Zou XF, Liu DT, Chen YP, Zhang H. Chen SB, et al. World J Gastroenterol. 2015 Jun 28;21(24):7514-21. doi: 10.3748/wjg.v21.i24.7514. World J Gastroenterol. 2015. PMID: 26139998 Free PMC article.

5

Targeting PAK4 reverses cisplatin resistance in NSCLC by modulating ER stress.

Liu S, Yang P, Wang L, Zou X, Zhang D, Chen W, Hu C, Xiao D, Ren H, Zhang H, Cai S. Liu S, et al. Among authors: zou x. Cell Death Discov. 2024 Jan 18;10(1):36. doi: 10.1038/s41420-024-01798-7. Cell Death Discov. 2024. PMID: 38238316 Free PMC article.

6

PRMT5-PAK1 Signaling Participates in Metastasis and Is Associated With Poor Prognosis in Human Esophageal Carcinoma.

Zou X, Lin Y, Ren H, Meng Y, Chen S, Jiang Y, Cui W, Gu Y, Guo L, Yi L, Zhang D, Zhang H, Wu G. Zou X, et al. Anticancer Res. 2024 Feb;44(2):593-604. doi: 10.21873/anticanres.16848. Anticancer Res. 2024. PMID: 38307587

7

Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.

Gu Y, Wu G, Zou X, Huang P, Yi L. Gu Y, et al. Among authors: zou x. Med Sci Monit. 2020 Feb 11;26:e920432. doi: 10.12659/MSM.920432. Med Sci Monit. 2020. PMID: 32043484 Free PMC article.

8

Optimal timing of antiviral therapy for patients with malignant tumor who presented with hepatitis B reactivation during chemotherapy and/or immunosuppressive therapy.

Zou X, Guo L, Gu Y, Yang Z, Huang P, Liu T, Zhao J, Wu G. Zou X, et al. J Cancer. 2020 Mar 15;11(12):3559-3566. doi: 10.7150/jca.40154. eCollection 2020. J Cancer. 2020. PMID: 32284752 Free PMC article.

9

Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.

Yi L, Huang P, Zou X, Guo L, Gu Y, Wen C, Wu G. Yi L, et al. Among authors: zou x. Pharmacol Res. 2020 Nov;161:105144. doi: 10.1016/j.phrs.2020.105144. Epub 2020 Aug 15. Pharmacol Res. 2020. PMID: 32810627

10

Clinical Significance and Immune Landscape of Recurrence-Associated Ferroptosis Signature in Early-Stage Lung Adenocarcinoma.

Yi L, Huang P, Gu Y, Wu G, Zou X, Guo L, Wen C, Zhu J, Zhao D. Yi L, et al. Among authors: zou x. Front Oncol. 2022 Jan 27;12:794293. doi: 10.3389/fonc.2022.794293. eCollection 2022. Front Oncol. 2022. PMID: 35155238 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,575 results

Search Page

Filters